Dr Alok Anshu , Dr Surjeet Dwivedi , Dr M Murali , Dr Harsha MP
{"title":"Necrotising soft tissue infection in the present era: an analysis of clinicopathological features and predictors of mortality","authors":"Dr Alok Anshu , Dr Surjeet Dwivedi , Dr M Murali , Dr Harsha MP","doi":"10.1016/j.sipas.2023.100163","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Necrotizing soft tissue infections (NSTI) and non-NSTI are frequently difficult to distinguish based on symptoms, signs, and investigations. High morbidity related to it can only be avoided by early detection and treatment.</p></div><div><h3>Aim</h3><p>This study examined demographic, clinicopathological, NSTI prognosis, and mortality factors.</p></div><div><h3>Methodology</h3><p>80 NSTI patients were retrospectively studied. Clinicopathological profile, surgical management, histological report, and LRINEC score were included. Mortality predictions were evaluated between survivors and non-survivors.</p></div><div><h3>Results</h3><p>73.8 percent of patients were male and the mean age was 55.4±9.6 years. Nonsurvivors averaged 11.88±0.72 LRINEC scores. Non-survivor CRP averaged 236.5±48.5 mg/l. Gp A Hemolytic Streptococci were most frequent (37.8 percent ). Diabetes was a significant mortality predictor. Total mortality was 20%.</p></div><div><h3>Conclusion</h3><p>NSTI remains a major killer. High mortality is linked to age, diabetes, higher blood creatinine, MODS, and delayed surgery.” and proceed accordingly.</p></div>","PeriodicalId":74890,"journal":{"name":"Surgery in practice and science","volume":"13 ","pages":"Article 100163"},"PeriodicalIF":0.6000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery in practice and science","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666262023000098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Necrotizing soft tissue infections (NSTI) and non-NSTI are frequently difficult to distinguish based on symptoms, signs, and investigations. High morbidity related to it can only be avoided by early detection and treatment.
Aim
This study examined demographic, clinicopathological, NSTI prognosis, and mortality factors.
Methodology
80 NSTI patients were retrospectively studied. Clinicopathological profile, surgical management, histological report, and LRINEC score were included. Mortality predictions were evaluated between survivors and non-survivors.
Results
73.8 percent of patients were male and the mean age was 55.4±9.6 years. Nonsurvivors averaged 11.88±0.72 LRINEC scores. Non-survivor CRP averaged 236.5±48.5 mg/l. Gp A Hemolytic Streptococci were most frequent (37.8 percent ). Diabetes was a significant mortality predictor. Total mortality was 20%.
Conclusion
NSTI remains a major killer. High mortality is linked to age, diabetes, higher blood creatinine, MODS, and delayed surgery.” and proceed accordingly.